NASDAQ:ATOS | Free Cash Flow | ATOSSA THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$9.58M$0.00-$9.58M
2025-12-31-$10.54M$7,000.00-$10.55M
2025-03-31-$5.96M$9,000.00-$5.97M
2024-12-31-$7.05M$0.00-$7.05M
2024-03-31-$4.7M$6,000.00-$4.7M
2023-12-31-$5.57M$0.00-$5.57M
2023-03-31-$7.02M$0.00-$7.02M
2022-12-31-$4.52M$8,000.00-$4.53M
2022-03-31-$4.88M$13,000.00-$4.89M
2021-12-31-$3.67M$0.00-$3.67M
2021-03-31-$4.41M$0.00-$4.41M
2020-12-31-$3.43M-$367.00-$3.43M
2020-03-31-$3.23M
2019-12-31-$2.71M$0.00-$2.71M
2019-03-31-$2.15M
2018-12-31-$2.44M$56,458.00-$2.5M
2018-03-31-$2.39M$51,068.00-$2.44M
2017-12-31-$1.68M
2017-03-31-$1.86M
2016-12-31-$1.36M
2016-03-31-$2.99M
2015-12-31-$3.95M
2015-03-31-$3M
2014-12-31-$2.72M
2014-03-31-$2.6M
2013-12-31-$2.65M
2013-03-31-$1.33M
2012-12-31-$1.93M
2012-03-31-$1.01M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$29.76M$23,000.00-$29.79M
2024-12-31-$21.03M$19,000.00-$21.05M
2023-12-31-$20.94M$14,000.00-$20.96M
2022-12-31-$20.76M$27,000.00-$20.79M
2021-12-31-$16.47M$9,000.00-$16.48M
2020-12-31-$11.57M$9,000.00-$11.58M
2019-12-31-$9.13M$7,625.00-$9.14M
2018-12-31-$8.96M$110,906.00-$9.07M
2017-12-31-$6.59M
2016-12-31-$5.37M
2015-12-31-$13.95M
2014-12-31-$10.56M
2013-12-31-$8.83M
2012-12-31-$3.9M
2011-12-31-$3.49M